| Literature DB >> 28228801 |
Elham Hariri1, Arash Mahboubi2, Mohammad Fathi3, Parisa Rahmani2, Kamaleddin Haj Mohammad Ebrahim Tehrani1, Mohammad Babaeian2, Vida Mashayekhi1, Farzad Kobarfard1.
Abstract
A series of hydroxyl semicarbazone derivatives of substituted diaryl ketones and acetophenones were synthesized and their structures were confirmed by analytical and spectroscopic methods including elemental analysis, infrared and nuclear magnetic resonance spectroscopy. The derivatives were prepared by a condensation reaction between N-hydroxy semicarbazide and substituted diaryl ketones or acetophenones leading to the desired hydroxysemicarbazones with excellent purity. The synthesized hydrazones were then evaluated for their inhibitory activity against bacterial strains including S. aureus, E. Coli, P. aeruginosa, K. pneumonia and M. luteus. Among the tested derivatives, compounds 2, 6 and 7 exhibited the highest bioactivity. Analysis of the activity data suggests that hydrophilicity is an important factor for the bioactivity of compounds 2 and 6 and also their selectivity over the gram-negative bacteria.Entities:
Keywords: Antibacterial; Broth microdilution assay; Hydrophilicity; Ketones; N-hydroxy semicarbazone
Year: 2016 PMID: 28228801 PMCID: PMC5242349
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Figure 1General structure of active (thio) semicarbazones. X = O, S; R = various aromatic and aliphatic substituents
Figure 2Antimycobacterial N-hydroxy semicarbazone derivatives reported by Sriram et al. (8).
Figure 3Design of the novel N-hydroxy semicarbazone derivatives based on the structural elements of active N-hydroxy thiosemicarbazones (left) and semicarbazones (right
Scheme 1Synthesis of N-hydroxy semicarbazones 1-6
Figure 4Structures of E (right) and Z (left) isomers of compound 3
Antibacterial activity of the synthesized derivatives
|
| MIC (µg/mL) | ||||
|---|---|---|---|---|---|
| 1 | > 1000 | 500 | 250 | 250 | 1000 |
| 2 | 500 | 125 | 125 | 62.5 | 500 |
| 3 | 125 | > 1000 | 500 | > 1000 | 250 |
| 4 | 125 | 1000 | 500 | 1000 | 62.5 |
| 5 | 1000 | 1000 | 1000 | 1000 | 1000 |
| 6 | 500 | 500 | 250 | 125 | 500 |
| 7 | 500 | 125 | 62.5 | 31.25 | 500 |
| Amikacin | 4 | 0.5 | 2 | 1 | 2 |
| Vancomycin | ≤ 4 | ≤ 4 | 32 | ≤ 4 | ≤ 2 |
| DMSO | + | + | + | + | + |